HOME >> BIOLOGY >> NEWS
Therapeutic cloning may be permitted at Newcastle University

A special licensing committee of the UK Human Fertilization & Embryology Authority (HFEA) met on June 16 in London to decide whether to grant a license to scientists at The Center for Life at Newcastle University. If approved, this will be the first license to begin research involving cell nuclear replacement (therapeutic cloning), focusing on the treatment of diabetes in the UK and will be a first in Europe.

Therapeutic cloning, for the derivation of embryonic stem cells, has the potential to lead to cures for serious diseases such as Alheizmer's, Parkinson's, heart failure and cancer. The UK has a strict regulatory system for human embryonic stem cell research. If the license is approved, it will allow this important work to begin. The UK was one of the first countries in the world to pass legislation to explicitly ban reproductive cloning.

Dr. Miodrag Stojkovic of Newcastle University who leads the research team said that he was very happy that the law in the UK allows scientists to work in this very promising field and use their knowledge in stem cell biology and nuclear transfer technique to bring faster and more efficient stem cells from the bench to the patient's bed.

Newcastle University's Institute of Human Genetics and the Life Fertility Center is one of only two groups in the UK to derive human ES (embryonic stem cells) from spare IVF embryos.

ES cells can be used to make any cell type in the body and replace cells that have been lost as a result of disease or injury. Cells derived from ES cells may often be genetically different from the patient, and transplanted cells could be rejected by the patient's immune system.

The Newcastle stem cell group will use nuclear transfer to derive stem cells that are genetically identical to those of a patient. In this case the stem cells and cells derived from them would not be rejected after being transplanted into a p
'"/>

Contact: Chris Pook
Chris.Pook@fco.gov.uk
202-588-6674
British Information Services
17-Jun-2004


Page: 1 2

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
4. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
5. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
6. Medimmune and Critical Therapeutics to co-develop treatments for severe inflammatory diseases
7. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
8. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
9. Immerge BioTherapeutics announces identification of PERV receptor
10. Hemocellular Therapeutics establishes licensing agreement with UNC, ECU
11. Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... 14, 2019 , ... IMMUNE 3D®, a privately held biotechnology ... of autoimmunity, fibrosis and skin immunology. In addition, the company will leverage its ... efforts. , IMMUNE 3D®’s proprietary platform aims to study factors that affect ...
(Date:5/8/2019)... ... May 08, 2019 , ... RG+A, Inc., ... Carol S. Mann has agreed to serve as Chief Executive Officer and pharmaceutical ... Officer, effective immediately. They will join Chairman and Founder Roger Green to create ...
(Date:5/7/2019)... ... May 07, 2019 , ... ... Beach Convention and Entertainment Center from May 15- 17. At booth #226, AMGtime ... These include flexible software, biometric hardware, mobile apps, specialized industry solutions, advanced add-on ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ... May 02, 2019 , ... Boston Robotic Hair ... area. Gone are the days of painful hair transplant procedures. Boston Robotic Hair ... is the only robotic intelligent solution to offer a minimally invasive procedure. With ...
(Date:4/25/2019)... , ... April 24, 2019 , ... ... Agents for sales and service organizations, today announced global availability of Inference ... providers and enterprises of all sizes to harness the power of Google’s ...
(Date:4/16/2019)... Md. (PRWEB) , ... April 16, 2019 , ... ... honor Blue Sources and their project partner, the U.S. Army Center for Environmental ... of Aquatic Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located ...
(Date:4/15/2019)... ... 2019 , ... Sirrus, Inc., a developer of novel electron-deficient ... to increase production of methylene malonate monomers and oligomers. , The expanded bench ... production facility, which is scheduled to break ground in 2019. “The expanded facility ...
Breaking Biology Technology:
Cached News: